CDER Office of Product Quality Ready To Go: New Structure Sends Strong Signal To Industry
This article was originally published in RPM Report
Executive Summary
It took a while, but the Office of Pharmaceutical Quality is finally ready to begin operations. Biopharma companies should recognize the declaration of FDA’s priorities, and respond accordingly.